Open access
Open access
Powered by Google Translator Translator

Psychiatry

RCT: Comparison of intranasal vs. intramuscular naloxone in opioid overdoses managed by ambulance staff.

14 Apr, 2022 | 08:23h | UTC

Comparison of intranasal and intramuscular naloxone in opioid overdoses managed by ambulance staff: a double-dummy, randomised, controlled trial – Addiction

Commentary: Breathing restored within 10 minutes for 80% of overdose patients using nasal spray – Norwegian University of Science and Technology

 


Economic evaluation: cost-effectiveness of installing barriers at bridge and cliff sites for suicide prevention in Australia.

14 Apr, 2022 | 08:01h | UTC

Cost-effectiveness of Installing Barriers at Bridge and Cliff Sites for Suicide Prevention in Australia – JAMA Network Open

Invited Commentary: Rethinking Suicide Prevention as a Public Health Issue – JAMA Network Open

 

Commentary on Twitter

 


USPSTF draft statement recommends screening for anxiety and depression in children and adolescents ages 8 to 18 years.

13 Apr, 2022 | 11:05h | UTC

Draft Statements:

Screening for Anxiety in Children and Adolescents – US Preventive Services Task Force

Screening for Depression and Suicide Risk in Children and Adolescents – US Preventive Services Task Force

Commentary:

USPSTF Recommends Anxiety, Depression Screening for Children – HealthDay

 


The burden of mental disorders, substance use disorders and self-harm among young people in Europe, 1990–2019: Findings from the Global Burden of Disease Study 2019.

13 Apr, 2022 | 11:03h | UTC

The burden of mental disorders, substance use disorders and self-harm among young people in Europe, 1990–2019: Findings from the Global Burden of Disease Study 2019 – The Lancet Regional Health Europe

Invited Commentary: The burden of young people’s mental health conditions in Europe: No cause for complacency – The Lancet Regional Health Europe

Related:

Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019.

New Global Burden of Disease analyses show depression and anxiety among the top causes of health burden worldwide, and a significant increase due to the COVID-19 pandemic.

 

Commentary on Twitter

(Article and images under a CC BY 4.0 license)

 


RCT: Automated virtual reality therapy to treat agoraphobic avoidance and distress in patients with psychosis.

13 Apr, 2022 | 10:31h | UTC

Automated virtual reality therapy to treat agoraphobic avoidance and distress in patients with psychosis (gameChange): a multicentre, parallel-group, single-blind, randomised, controlled trial in England with mediation and moderation analyses – The Lancet Psychiatry

News Release: Breakthrough success in provision of automated psychological therapy using virtual reality – University of Oxford

 

Commentary from the author on Twitter

 


Systematic Review: Control interventions in randomized trials among people with mental health disorders.

13 Apr, 2022 | 09:38h | UTC

Control interventions in randomised trials among people with mental health disorders – Cochrane Library

Summary: Control interventions in randomised trials for people with a mental health disorder – Cochrane Library

Featured review: Control interventions in randomized trials among people with mental health disorders

 


Perspective: Supervised consumption sites—a tool for reducing risk of overdose deaths and infectious diseases in people who use illicit drugs.

11 Apr, 2022 | 00:59h | UTC

Supervised Consumption Sites—A Tool for Reducing Risk of Overdose Deaths and Infectious Diseases in People Who Use Illicit Drugs – JAMA (free for a limited period)

 

Commentary on Twitter

 


Autistic people are six times more likely to attempt suicide – poor mental health support may be to blame.

8 Apr, 2022 | 10:02h | UTC

Autistic people are six times more likely to attempt suicide – poor mental health support may be to blame – The Conversation

 


Cohort Study: Comparison of rates of Type 2 Diabetes in adults and children treated with anticonvulsant mood stabilizers.

7 Apr, 2022 | 08:32h | UTC

Comparison of Rates of Type 2 Diabetes in Adults and Children Treated With Anticonvulsant Mood Stabilizers – JAMA Network Open

 

Commentary on Twitter

 


M-A: Immediate and sustained outcomes and moderators associated with metacognitive training for psychosis.

7 Apr, 2022 | 08:10h | UTC

Immediate and Sustained Outcomes and Moderators Associated With Metacognitive Training for Psychosis: A Systematic Review and Meta-analysis – JAMA Psychiatry

Commentary: Therapy Challenging Cognitive Biases Reduces Symptoms of Psychosis, Meta-Analysis Suggests – Psychiatry News Alert

 


Global, regional, and national trends in opioid analgesic consumption from 2015 to 2019.

6 Apr, 2022 | 10:49h | UTC

Global, regional, and national trends in opioid analgesic consumption from 2015 to 2019: a longitudinal study – The Lancet Public Health

News Release: Global disparities persist in opioid painkiller access – University College London

Invited Commentary: Closing the global pain divide: balancing access and excess – The Lancet Public Health

 

Commentary on Twitter (article and images under a Creative Commons Attribution (CC BY 4.0 license)

 


Opinion | Medicinal cannabis for chronic pain: the Bermuda triangle of low-quality studies, countless meta-analyses and conflicting recommendations.

5 Apr, 2022 | 08:52h | UTC

Medicinal Cannabis for Chronic Pain: The Bermuda Triangle of Low Quality Studies, Countless Meta-analyses and Conflicting Recommendations – European Journal of Pain

Related:

RCT: Effect of medical marijuana card ownership on pain, insomnia, and affective disorder symptoms in adults.

Cohort Study: Long-term cannabis use is associated with cognitive deficits and smaller hippocampal volume in midlife.

AHA Scientific Statement | How does cannabis use affect brain health? Caution advised, more research needed.

M-A: Birth outcomes of neonates exposed to marijuana in utero.

Cannabis-related allergies: an international overview and consensus recommendations.

Review: Cannabis-based medicines and medical cannabis for chronic neuropathic pain.

Cannabinoid metabolites as inhibitors of major hepatic CYP450 enzymes, with implications for cannabis-drug interactions.

Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain.

The International Cannabis Toolkit (iCannToolkit): a multidisciplinary expert consensus on minimum standards for measuring cannabis use.

Cannabis products are being sold as sleep remedies – here’s the evidence about their effectiveness.

Guideline: Medical cannabis or cannabinoids for chronic pain.

Cannabis and Cannabinoid Analgesia position statement – “Due to the lack of high-quality clinical evidence, the IASP does not currently endorse general use of cannabis and cannabinoids for pain relief.”

NICE Guideline: Cannabis-Based Medicinal Products

Consensus recommendations for perioperative management of cannabis and cannabinoid-based medicine users

Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain – Agency for Healthcare Research and Quality

Short Review: Drug Interactions with Cannabinoids

Meta-Analysis: Cannabinoids Not Effective for Cancer-Related Pain

Review: Considerations for cannabinoids in perioperative care by anesthesiologists.

Review: Cannabis-based Medicines and the Perioperative Physician

Study: Cannabis Use Disorder May Increase the Risk of Cardiovascular Events in Major Elective Surgeries

Perspective: If You Smoke Pot, Your Anesthesiologist Needs To Know

Perioperative Care of Cannabis Users: A Comprehensive Review of Pharmacological and Anesthetic Considerations

 


WHO’s training for caregivers of children with autism goes online.

4 Apr, 2022 | 00:59h | UTC

News Release: WHO’s training for caregivers of children with autism goes online – World Health Organization

Online Course: WHO eLearning Caregiver Skills Training for Families of Children with Developmental Delays or Disabilities – OpenWHO

 


RCT: Effect of medical marijuana card ownership on pain, insomnia, and affective disorder symptoms in adults.

1 Apr, 2022 | 10:07h | UTC

Effect of Medical Marijuana Card Ownership on Pain, Insomnia, and Affective Disorder Symptoms in Adults: A Randomized Clinical Trial – JAMA Network Open

Commentaries:

Marijuana for medical use may result in rapid onset of cannabis use disorder – Massachusetts General Hospital

Study raises questions about risks of using medical marijuana for mood and anxiety disorders – CNN

Medical Marijuana Rx Ups Odds for Overuse, With No Benefit to Health: Study – HealthDay

 

Commentary on Twitter

 


RCT: Amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia.

1 Apr, 2022 | 09:47h | UTC

Amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia in Germany (COMBINE): a double-blind randomised controlled trial – The Lancet Psychiatry (link to abstract – $ for full-text)

 

Commentary on Twitter

 


M-A: Psychological interventions for chronic, non-specific low back pain.

31 Mar, 2022 | 08:20h | UTC

Psychological interventions for chronic, non-specific low back pain: systematic review with network meta-analysis – The BMJ

News Release: Study sheds light on psychological therapies for chronic low back pain – British Medical Journal

 


Cohort Study: Mortality associated with mental disorders and comorbid general medical conditions.

31 Mar, 2022 | 08:15h | UTC

Mortality Associated With Mental Disorders and Comorbid General Medical Conditions – JAMA Psychiatry

Commentary: People with Mental Disorders, General Comorbid Conditions Have 11-Year Reduced Life Expectancy – HCP Live

 


Systematic Review: The global gap in treatment coverage for major depressive disorder in 84 countries from 2000–2019.

30 Mar, 2022 | 09:49h | UTC

The global gap in treatment coverage for major depressive disorder in 84 countries from 2000–2019: A systematic review and Bayesian meta-regression analysis – PLOS Medicine

Commentary: PLOS Medicine: Study highlights worldwide disparities in treatment rates for major depressive disorder – Institute for Health Metrics and Evaluation

 


M-A: Effectiveness of cognitive–behavioral therapies of varying complexity in reducing depression in adults.

30 Mar, 2022 | 09:46h | UTC

Effectiveness of cognitive–behavioural therapies of varying complexity in reducing depression in adults: systematic review and network meta-analysis – British Journal of Psychiatry (link to abstract – $ for full-text)

News Release: Enhanced CBT can radically reduce long-term depression, finds study – University of Manchester

 


Cumulative burden of psychiatric disorders and self-harm across 26 adult cancers.

29 Mar, 2022 | 09:58h | UTC

Cumulative burden of psychiatric disorders and self-harm across 26 adult cancers – Nature Medicine

See also: Suicide risk and mortality among patients with cancer – Nature Medicine (if the link is paywalled, try this one)

Invited Commentary: Shining a light on the psychological burden of cancer – Nature Medicine

 

Commentary on Twitter

 


Scientists find that the impact of social media on wellbeing varies across adolescence.

29 Mar, 2022 | 09:56h | UTC

News Release: Scientists find that the impact of social media on wellbeing varies across adolescence – University of Cambridge

Original Study: Windows of developmental sensitivity to social media – Nature Communications

Commentaries:

Negative impact of social media affects girls and boys at different ages – study – University of Oxford

Teenage social media use linked to less life-satisfaction for some – BBC

Social media may affect girls’ mental health earlier than boys’, study finds – The Guardian

Expert reaction to study on social media use and wellbeing over adolescence – Science Media Centre

 


Association of antipsychotic drug exposure in pregnancy with risk of neurodevelopmental disorders: a national birth cohort study.

29 Mar, 2022 | 08:46h | UTC

Association of Antipsychotic Drug Exposure in Pregnancy With Risk of Neurodevelopmental Disorders: A National Birth Cohort Study – JAMA Internal Medicine (free for a limited period)

Commentary: Antipsychotic Use During Pregnancy Generally Not Associated With Neurodevelopmental Risks – Psychiatric News Alert

 


European clinical guidelines for Tourette syndrome and other tic disorders.

29 Mar, 2022 | 08:26h | UTC

Summary statement

Part I: assessment

Part II: psychological interventions

Part III: pharmacological treatment

Part IV: deep brain stimulation

Related: Guideline: Treatment of Tics in People with Tourette Syndrome and Chronic Tic Disorders

 


Study challenges the theory that light alcohol consumption benefits heart health.

28 Mar, 2022 | 10:09h | UTC

News Release: Large study challenges the theory that light alcohol consumption benefits heart health – Massachusetts General Hospital

Original Study: Association of Habitual Alcohol Intake With Risk of Cardiovascular Disease – JAMA Network Open

Related: No amount of alcohol is good for the heart, says World Heart Federation.

 

Commentary on Twitter

 


Cohort study: Long-term treatment with clozapine is associated with increased risk of hematological malignancies.

28 Mar, 2022 | 08:43h | UTC

Long-term treatment with clozapine and other antipsychotic drugs and the risk of haematological malignancies in people with schizophrenia: a nationwide case-control and cohort study in Finland – The Lancet Psychiatry (link to abstract – $ for full-text)

 

Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.